infliximab

From infl(ammatory) +‎ -li- (“immunomodulating”) +‎ -ximab (“chimeric monoclonal antibody”).

• (General American) IPA^(key): /ɪnˈflɪk.sɪˌmæb/

infliximab (uncountable)

1. (pharmacology) An immunosuppressive drug (trademark Remicade) administered by intravenous injection especially to treat the symptoms of Crohn's disease, ulcerative colitis, and rheumatoid arthritis. It is a chimeric monoclonal antibody prepared from humans and mice that acts by binding to and blocking the activity of tumor necrosis factor.

• “infliximab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.

• IPA^(key): /infliɡsiˈmab/ [ĩɱ.fliɣ̞.siˈmaβ̞]
• Rhymes: -ab
• Syllabification: in‧fli‧xi‧mab

infliximab m (uncountable)

1. (pharmacology) infliximab